Table 2 Univariate and multivariate Cox regression analyses and multicollinearity analysis of PVT in cirrhosis patients with CHB.
Variables | UNI | MULTI | |||
---|---|---|---|---|---|
P | HR (95%CI) | VIF | P | HR (95%CI) | |
Gender | 1.367 | ||||
Male | - | 1.00 (Reference) | |||
Female | 0.720 | 0.84 (0.33 ~ 2.14) | |||
Baseline HBV DNA level | 1.410 | ||||
Low | - | 1.00 (Reference) | |||
Moderate | 0.891 | 0.94 (0.39 ~ 2.25) | |||
High | 0.083 | 0.16 (0.02 ~ 1.28) | |||
HBV DNA level after therapy | 1.764 | ||||
Low | - | 1.00 (Reference) | |||
Moderate | < 0.001 | 5.21 (2.18 ~ 12.45) | |||
High | 0.332 | 2.73 (0.36 ~ 20.82) | |||
Antiviral responses | 2.075 | ||||
VR | - | 1.00 (Reference) | 1.00 (Reference) | ||
PVR | < 0.001 | 22.52 (4.54 ~ 111.66) | 0.333 | 2.48 (0.39 ~ 15.53) | |
PNR | 0.006 | 30.09 (2.70 ~ 335.92) | 0.051 | 15.94 (0.99 ~ 257.16) | |
VBT | < 0.001 | 65.60 (14.79 ~ 290.95) | < 0.001 | 42.48 (5.02 ~ 359.89) | |
HCC | 2.096 | ||||
No | - | 1.00 (Reference) | 1.00 (Reference) | ||
Yes | < 0.001 | 14.29 (6.03 ~ 33.89) | < 0.001 | 30.69 (5.50 ~ 171.15) | |
Spleen size | 2.491 | ||||
Normal | - | 1.00 (Reference) | |||
Largish | 1.000 | 1.00 (0.00 ~ Inf) | |||
Large | 0.997 | 931,361,065.72 (0.00 ~ Inf) | |||
Diabetes | 1.192 | ||||
No | - | 1.00 (Reference) | |||
Yes | 0.841 | 0.81 (0.11 ~ 6.08) | |||
Hypertension | 1.333 | ||||
No | - | 1.00 (Reference) | |||
Yes | 0.644 | 0.62 (0.08 ~ 4.63) | |||
HBeAg | |||||
Non-reactive | 1.00 (Reference) | ||||
Reactive | 0.213 | 0.60 (0.27 ~ 1.34) | |||
HBeAb | |||||
Non-reactive | 1.00 (Reference) | ||||
Reactive | 0.093 | 1.94 (0.89 ~ 4.20) | |||
Cirrhosis degree | < 0.001 | 2.37 (1.72 ~ 3.27) | 2.791 | 0.069 | 1.25 (1.09 ~ 1.38) |
Antiviral drugs | 0.442 | 1.15 (0.81 ~ 1.64) | 1.251 | ||
Age | 0.002 | 1.06 (1.02 ~ 1.10) | 1.478 | 0.145 | 0.96 (0.90 ~ 1.02) |
Baseline HBV DNA Loads | 0.207 | 1.00 (1.00 ~ 1.00) | 1.410 | ||
HBV DNA loads after therapy | 0.834 | 1.00 (1.00 ~ 1.00) | 1.764 | ||
Portal vein diameter | < 0.001 | 13.20 (5.32 ~ 32.75) | 2.086 | 0.121 | 0.25 (0.04 ~ 1.44) |
Spleen major axis | < 0.001 | 1.37 (1.26 ~ 1.49) | 2.491 | < 0.001 | 1.49 (1.21 ~ 1.84) |
Antiviral therapy time | < 0.001 | 1.01 (1.01 ~ 1.01) | 1.426 | ||
AFP | 0.100 | 1.00 (1.00 ~ 1.00) | 1.292 | ||
D-dimer | < 0.001 | 1.01 (1.01 ~ 1.01) | 1.852 | 0.115 | 0.98 (0.91 ~ 1.01) |
APTT | 0.967 | 1.00 (0.94 ~ 1.06) | 1.841 | ||
INR | 0.003 | 5.24 (1.75 ~ 15.70) | 22.777 | ||
Fib | 0.061 | 1.78 (0.97 ~ 3.26) | 1.743 | ||
PT | 0.006 | 1.15 (1.04 ~ 1.27) | 22.419 | ||
PLT | < 0.001 | 0.98 (0.97 ~ 0.99) | 2.308 | 0.145 | 0.99 (0.90 ~ 1.06) |
MPV | 0.023 | 1.49 (1.06 ~ 2.11) | 1.234 | 0.156 | 0.87 (0.84 ~ 0.98) |
ALT | 0.752 | 1.00 (1.00 ~ 1.00) | 7.435 | ||
AST | 0.468 | 1.00 (1.00 ~ 1.00) | 7.724 | ||
GGT | 0.089 | 1.00 (1.00 ~ 1.01) | 2.110 | ||
ALP | < 0.001 | 1.01 (1.01 ~ 1.02) | 1.565 | 0.395 | 1.01 (1.01 ~ 1.01) |
T-Bil | 0.013 | 1.01 (1.01 ~ 1.01) | 1.515 | 0.096 | 1.01 (1.01 ~ 1.01) |
HDL | 0.030 | 1.13 (1.01 ~ 1.27) | 1.204 | 0.135 | 1.03 (1.01 ~ 1.09) |
LDL | 0.339 | 0.73 (0.38 ~ 1.39) | 17.355 | ||
TG | 0.399 | 0.70 (0.31 ~ 1.60) | 1.410 | ||
TC | 0.309 | 0.82 (0.57 ~ 1.20) | 17.907 | ||
HBsAg | 0.002 | 1.01 (1.01 ~ 1.02) | 1.268 | 0.007 | 1.03 (1.01 ~ 1.05) |
HBsAb | < 0.001 | 1.01 (1.01 ~ 1.02) | 1.478 | 0.004 | 1.02 (1.01 ~ 1.03) |
HBcAb | 0.722 | 0.97 (0.84 ~ 1.13) | 1.297 |